Search by Drug Name or NDC
NDC 60760-0773-30 Ethacrynic Acid 25 mg/1 Details
Ethacrynic Acid 25 mg/1
Ethacrynic Acid is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ST. MARY'S MEDICAL PARK PHARMACY. The primary component is ETHACRYNIC ACID.
MedlinePlus Drug Summary
Ethacrynic acid is used to treat edema (fluid retention; excess fluid held in body tissues) in adults and children caused by medical problems such as cancer, heart, kidney, or liver disease. Ethacrynic acid is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.
Related Packages: 60760-0773-30Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Ethacrynic Acid
Product Information
| NDC | 60760-0773 |
|---|---|
| Product ID | 60760-773_f4e95ca1-502c-5305-e053-2995a90a5dc7 |
| Associated GPIs | |
| GCN Sequence Number | 008201 |
| GCN Sequence Number Description | ethacrynic acid TABLET 25 MG ORAL |
| HIC3 | R1M |
| HIC3 Description | LOOP DIURETICS |
| GCN | 34910 |
| HICL Sequence Number | 003659 |
| HICL Sequence Number Description | ETHACRYNIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Ethacrynic Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ethacrynic Acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | ETHACRYNIC ACID |
| Labeler Name | ST. MARY'S MEDICAL PARK PHARMACY |
| Pharmaceutical Class | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211232 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60760-0773-30 (60760077330)
| NDC Package Code | 60760-773-30 |
|---|---|
| Billing NDC | 60760077330 |
| Package | 30 TABLET in 1 BOTTLE, PLASTIC (60760-773-30) |
| Marketing Start Date | 2023-02-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |